These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34261897)

  • 21. Overlap syndromes of autoimmune hepatitis: an open question.
    Durazzo M; Premoli A; Paschetta E; Belci P; Spandre M; Bo S
    Dig Dis Sci; 2013 Feb; 58(2):344-8. PubMed ID: 23086110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease: Early Diagnosis and Management Affect Clinical Outcome.
    Hensel KO; Kyrana E; Hadzic N; Mann J; Mieli-Vergani G; Gasparetto M; Heuschkel R; Noble-Jamieson G; Samyn M
    J Pediatr; 2021 Nov; 238():50-56.e3. PubMed ID: 34303727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
    Liberal R; Vergani D; Mieli-Vergani G
    Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autoimmune hepatitis in children].
    Olbjørn C; Sanengen T
    Tidsskr Nor Laegeforen; 2007 Jan; 127(1):19-22. PubMed ID: 17205083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge issues in juvenile sclerosing cholangitis.
    Di Giorgio A; Vergani D; Mieli-Vergani G
    Dig Liver Dis; 2022 Apr; 54(4):417-427. PubMed ID: 34289942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Insights into Pediatric Primary Sclerosing Cholangitis.
    Stevens JP; Gupta NA
    Clin Liver Dis; 2022 Aug; 26(3):489-519. PubMed ID: 35868687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary sclerosing cholangitis: a clinical update.
    Williamson KD; Chapman RW
    Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
    Bosch DE; Yeh MM
    Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population-Single Center Study.
    Wiecek S; Wojtyniak A; Pindur B; Machnikowska-Sokołowska M; Gruszczyńska K; Grzybowska-Chlebowczyk U
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34199130
    [No Abstract]   [Full Text] [Related]  

  • 30. Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease.
    Hadley T; Gillespie S; Espinoza H; Prince J; Gronbaek H; Chandrakasan S; Kuguthasan S; Kolachala VL; Gupta NA
    Autoimmunity; 2020 Aug; 53(5):253-260. PubMed ID: 32370568
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatobiliary disease in inflammatory bowel disease.
    Ahmad J; Slivka A
    Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.
    Zhang X; Lin X; Li X; Guan L; Li Y; Wang N
    Front Immunol; 2023; 14():1132072. PubMed ID: 37228618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology of Autoimmune Liver Disease].
    Heo NY
    Korean J Gastroenterol; 2023 Feb; 81(2):59-65. PubMed ID: 36824033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity.
    López Serrano P; Turnes Vázquez J
    Rev Esp Enferm Dig; 2020 Oct; 112(10):745-747. PubMed ID: 32954780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease.
    Nedelkopoulou N; Vadamalayan B; Vergani D; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):100-105. PubMed ID: 28953529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome.
    Jing M; Zhang W; Xia M
    Rev Esp Enferm Dig; 2022 Dec; 114(12):765-766. PubMed ID: 36205327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
    Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
    Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
    Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
    World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI; Kang SB
    Korean J Gastroenterol; 2019 May; 73(5):248-259. PubMed ID: 31132831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature.
    Larsen EP; Bayat A; Vyberg M
    Diagn Pathol; 2012 Aug; 7():100. PubMed ID: 22891962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.